Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
SiriusPoint
SPNT
$2.66B
| $15.6M | 0.01% |
1,482,945
-108,081
| -7% | -$1.05M |
|
1152
First Hawaiian
FHB
$3.36B
| $15.6M | 0.01% |
539,800
+157,900
| +41% | +$4.44M |
|
1153
Sherwin-Williams
SHW
$87.8B
| $15.6M | 0.01% |
+80,061
| New | +$15.3M |
|
|
CO
1154
DELISTED
Global Cord Blood Corporation
CO
| $15.6M | 0.01% |
3,114,337
+98,332
| +3% | +$470K |
|
1155
Ethan Allen Interiors
ETD
$575M
| $15.5M | 0.01% |
815,400
-143,300
| -15% | -$2.67M |
|
|
KRA
1156
DELISTED
Kraton Corporation
KRA
| $15.5M | 0.01% |
612,200
-37,700
| -6% | -$912K |
|
|
CMO
1157
DELISTED
Capstead Mortgage Corp.
CMO
| $15.5M | 0.01% |
1,951,200
-147,200
| -7% | -$1.14M |
|
1158
Spectrum Brands
SPB
$2.03B
| $15.4M | 0.01% |
240,084
+167,288
| +230% | +$9.48M |
|
|
Y
1159
DELISTED
Alleghany Corp
Y
| $15.4M | 0.01% |
19,288
-38,000
| -66% | -$29.7M |
|
1160
Community Trust Bancorp
CTBI
$1.44B
| $15.4M | 0.01% |
330,605
-11,877
| -3% | -$526K |
|
1161
Copart
CPRT
$27.2B
| $15.3M | 0.01% |
674,400
-1,814,800
| -73% | -$38.7M |
|
1162
Atkore
ATKR
$3.17B
| $15.3M | 0.01% |
378,800
+113,700
| +43% | +$4.21M |
|
1163
White Mountains Insurance
WTM
$5.06B
| $15.3M | 0.01% |
13,700
+1,200
| +10% | +$1.31M |
|
1164
Inogen
INGN
$154M
| $15.3M | 0.01% |
223,500
-88,600
| -28% | -$5.56M |
|
|
MCHB
1165
Mechanics Bancorp
MCHB
$3.8B
| $15.3M | 0.01% |
448,700
+64,900
| +17% | +$2.01M |
|
1166
Artesian Resources
ARTNA
$362M
| $15.2M | 0.01% |
409,010
+7,000
| +2% | +$259K |
|
1167
W.R. Berkley
WRB
$25.9B
| $15.2M | 0.01% |
+495,450
| New | +$15.3M |
|
|
HAYN
1168
DELISTED
Haynes International, Inc.
HAYN
| $15.2M | 0.01% |
423,946
+47,500
| +13% | +$1.71M |
|
|
SHYF
1169
DELISTED
The Shyft Group
SHYF
| $15.2M | 0.01% |
838,744
-53,647
| -6% | -$896K |
|
|
CNBKA
1170
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $15.2M | 0.01% |
168,501
+20,752
| +14% | +$1.81M |
|
1171
A10 Networks
ATEN
$2B
| $15.1M | 0.01% |
2,205,000
-67,400
| -3% | -$453K |
|
1172
Arrow Financial
AROW
$723M
| $15.1M | 0.01% |
449,382
+24,139
| +6% | +$759K |
|
|
MNTA
1173
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $15.1M | 0.01% |
764,848
-532,638
| -41% | -$8.52M |
|
|
HPR
1174
DELISTED
HighPoint Resources Corporation
HPR
| $15.1M | 0.01% |
178,452
+9,526
| +6% | +$620K |
|
1175
PTC Therapeutics
PTCT
$6.01B
| $15.1M | 0.01% |
313,900
+183,600
| +141% | +$7.8M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.